STAT - Reporting from the frontiers of health and medicine

Health Tech

Politics

First Opinion

By Frank Lin, Charlotte Yeh, and Christine Cassel

First Opinion Responsible AI: leveraging data and technology to counteract bias
Health Tech With a nudge from AI, ketamine emerges as a potential rare disease treatment
The Readout LOUD Listen: The mRNA gold rush, Delta’s alarming rise, & the next treatment for Alzheimer’s
In the Lab Scientists plumbing mysterious RNAs in the human genome find a possible treatment for an inherited disorder
Exclusive Athira cited altered studies in $15 million NIH grant application, creating legal risk

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Adagio raises $300 million in IPO, looks to advance Covid-19 antibody therapy
A federal appeals court throws into question the fate of ‘skinny labels’ — and access to generic drugs
Bayer inks a $1.5 billion deal for a biotech with a proprietary drug discovery platform

Health

By Marion Renault

Biotech

A STAT Investigation

Health

Health Tech

Health

Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Health Tech With a nudge from AI, ketamine emerges as a potential rare disease treatment
Health Tech As HIMSS approaches, plans for health tech’s biggest gathering are clashing with Covid-19 concerns
Health How the Covid pandemic ends: Scientists look to the past to see the future
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Health The Covid-19 Tracker
Politics Desperate for relief amid Covid-19, hospitals find an uncommonly staunch advocate in Susan Collins
Health People chasing Covid-19 vaccine boosters create headaches for the health care system